Treatment Duration and Disease Recurrence Following the Successful Treatment of Patients With Mycobacterium avium Complex Lung Disease

Chest. 2020 Jun;157(6):1442-1445. doi: 10.1016/j.chest.2019.12.016. Epub 2020 Jan 16.

Affiliations

¹ Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan.
² Respiratory Disease Center, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan; Division of Clinical Research, Fukujuji Hospital, Japan Anti-Tuberculosis Association, Tokyo, Japan. Electronic address: morimotok@fukujuji.org.
³ Department of Respiratory Medicine, National Hospital Organization, Minami Kyoto Hospital, Joyo, Japan.

PMID: 31954692
DOI: 10.1016/j.chest.2019.12.016

No abstract available

MeSH terms

Aged
Anti-Bacterial Agents / therapeutic use*
Duration of Therapy
Female
Follow-Up Studies
Humans
Lung Diseases / drug therapy*
Lung Diseases / microbiology
Male
Middle Aged
Mycobacterium avium Complex / isolation & purification
Mycobacterium avium-intracellulare Infection / drug therapy*
Mycobacterium avium-intracellulare Infection / microbiology
Recurrence
Retrospective Studies
Treatment Outcome

Substances

Anti-Bacterial Agents